Selected Consolidated Financial Statement Information

9 Months Ended

Mar. 31, 2020

Quarterly Financial Information Disclosure [Abstract]

Selected Consolidated Financial Statement Information

2. Selected Consolidated Financial Statement Information

Accounts Receivable, Net

Accounts receivable consists of the following:

	March 31,		June 30,
	2020		2019
Accounts receivable	$	31,935	$	36,628
Less: Allowance for doubtful accounts	(1,071)		(613)
Accounts receivable, net	$	30,864	$	36,015

Inventories

Inventories consist of the following:

	March 31,		June 30,
	2020		2019
Raw materials	$	7,752	$	5,547
Work in process	2,533		1,415
Finished goods	13,784		11,096
Inventories	$	24,069	$	18,058

Property and Equipment, Net

Property and equipment consists of the following:

	March 31,		June 30,
	2020		2019
Land	$	572	$	572
Building	22,420		22,420
Equipment	18,235		17,517
Furniture	3,207		2,975
Leasehold improvements	663		540
Construction in progress	2,855		1,328
	47,952		45,352
Less: Accumulated depreciation	(20,260)		(18,028)
Property and equipment, net	$	27,692	$	27,324

Accrued Expenses

Accrued expenses consist of the following:

	March 31,		June 30,
	2020		2019
Acquisition consideration	$	9,829	$	—
Salaries and bonus	6,908		11,105
Accrued vacation	5,043		4,230
Commissions	4,689		6,829
Accrued excise, sales and other taxes	2,492		3,349
Clinical studies	2,639		2,092
Other accrued expenses	3,464		1,782
Accrued expenses	$	35,064	$	29,387